Atlas Trials

Ketamine in Borderline Personality Disorder

Clinical trial NCT03395314 · TERMINATED

Trial details

NCT number
NCT03395314
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Borderline Personality Disorder
Start date
2018-02-15
Primary completion
2022-05-06
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.